Promising advances in #ImmuneThrombocytopenia (ITP) treatment: #SpleenTyrosineKinase and Bruton's tyrosine kinase inhibitors like fostamatinib, sovleplenib, rilzabrutinib, and orelabrutinib improve platelet counts and safety in refractory #ITP #Aminopyridines. onlinelibrary.wiley.com/doi/10.1155/...
Efficacy and Safety of Syk and BTK Inhibitors in Immune Thrombocytopenia: A Comprehensive Review of Emerging Evidence
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by a reduced platelet count, resulting in bleeding risks and compromised quality of life. Advances in understanding ITP pathogene....
onlinelibrary.wiley.com
August 13, 2025 at 6:52 AM
Promising advances in #ImmuneThrombocytopenia (ITP) treatment: #SpleenTyrosineKinase and Bruton's tyrosine kinase inhibitors like fostamatinib, sovleplenib, rilzabrutinib, and orelabrutinib improve platelet counts and safety in refractory #ITP #Aminopyridines. onlinelibrary.wiley.com/doi/10.1155/...